Skip to main content
Equibles

MORGAN STANLEY

Position in ANRO — Alto Neuroscience, Inc.

CIK 895421 NEW YORK, NY
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,977,665
+$434,326 QoQ
Shares Held
74,940
+9.2% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 114 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ANRO ranks #214 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ANRO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,977,665 74,940
2026-03-31 $1,543,339 68,654
2025-12-31 $1,167,339 65,581
2025-09-30 $245,363 61,036
2025-06-30 $142,184 64,630
2025-03-31 $101,100 46,807
2024-12-31 $857,168 202,641
2024-09-30 $871,278 76,161
2024-06-30 $281,391 26,323
2024-03-31 $203,923 13,285